These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 8791119)

  • 41. Chemoprevention options for BRCA1 and BRCA2 mutation carriers.
    Eeles RA; Powles TJ
    J Clin Oncol; 2000 Nov; 18(21 Suppl):93S-9S. PubMed ID: 11060334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Terpenoids and breast cancer chemoprevention.
    Rabi T; Bishayee A
    Breast Cancer Res Treat; 2009 May; 115(2):223-39. PubMed ID: 18636327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel concepts for the chemoprevention of breast cancer through aromatase inhibition.
    Kendall A; Dowsett M
    Endocr Relat Cancer; 2006 Sep; 13(3):827-37. PubMed ID: 16954432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical trials referral resource. Breast cancer and prostate cancer.
    Brawley OW; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 Jan; 10(1):100, 102. PubMed ID: 8924360
    [No Abstract]   [Full Text] [Related]  

  • 45. Continuation of the International Breast Cancer Intervention Study (IBIS).
    Cuzick J
    Eur J Cancer; 1998 Oct; 34(11):1647-8. PubMed ID: 9893646
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of fenretinide on ovarian carcinoma occurrence.
    De Palo G; Mariani L; Camerini T; Marubini E; Formelli F; Pasini B; Decensi A; Veronesi U
    Gynecol Oncol; 2002 Jul; 86(1):24-7. PubMed ID: 12079295
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lessons learned from lung cancer chemoprevention trials.
    Kim ES
    Nat Clin Pract Oncol; 2009 Jan; 6(1):1. PubMed ID: 19096395
    [No Abstract]   [Full Text] [Related]  

  • 48. Breast cancer prevention trials using retinoids.
    Decensi A; Serrano D; Bonanni B; Cazzaniga M; Guerrieri-Gonzaga A
    J Mammary Gland Biol Neoplasia; 2003 Jan; 8(1):19-30. PubMed ID: 14587861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chemoprevention trends in breast cancer.
    Lazzaro M; Mizell V; Thompson M; Weber D
    Adv Nurse Pract; 1998 Nov; 6(11):26-8, 33-4, 74. PubMed ID: 9919058
    [No Abstract]   [Full Text] [Related]  

  • 50. Progress in chemoprevention of breast cancer.
    Serrano D; Perego E; Costa A; Decensi A
    Crit Rev Oncol Hematol; 2004 Feb; 49(2):109-17. PubMed ID: 15012972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Specific keynote: chemoprevention of ovarian cancer: the journey begins.
    Ozols RF; Daly MB; Klein-Szanto A; Hamilton TC; Bast RC; Brewer MA
    Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S59-66; discussion S67-70. PubMed ID: 12586088
    [No Abstract]   [Full Text] [Related]  

  • 52. Women at high risk for breast cancer: preventive strategies.
    Sakorafas GH
    Mt Sinai J Med; 2002 Sep; 69(4):264-6. PubMed ID: 12357269
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chemoprevention of breast cancer: a literature review and report on the current status in Germany].
    Paepke S; V Minckwitz G; Kaufmann M; Schwarz-Boeger U; Jacobs VR; Aigner M; Pfeifer K; Ehmer M; Hüttner C; Blohmer JU; Kiechle M
    Zentralbl Gynakol; 2003 Sep; 125(9):338-45. PubMed ID: 14569515
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chemoprevention of breast cancer with fenretinide.
    Torrisi R; Decensi A; Formelli F; Camerini T; De Palo G
    Drugs; 2001; 61(7):909-18. PubMed ID: 11434448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fenretinide: a prototype cancer prevention drug.
    Malone W; Perloff M; Crowell J; Sigman C; Higley H
    Expert Opin Investig Drugs; 2003 Nov; 12(11):1829-42. PubMed ID: 14585058
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast cancer chemoprevention: clinical trials and research.
    Noguchi M; Rose DP; Miyazaki I
    Oncology; 1996; 53(3):175-81. PubMed ID: 8643218
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surrogate response biomarkers in prevention research: do they point the way or lead us astray?
    Fabian CJ
    J Clin Oncol; 2009 Aug; 27(23):3734-6. PubMed ID: 19597020
    [No Abstract]   [Full Text] [Related]  

  • 58. Phase II chemoprevention trial of oral fenretinide in patients at risk for adenocarcinoma of the prostate.
    Pienta KJ; Esper PS; Zwas F; Krzeminski R; Flaherty LE
    Am J Clin Oncol; 1997 Feb; 20(1):36-9. PubMed ID: 9020285
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemoprevention of breast cancer with fenretinide (4-HPR): study of long-term visual and ophthalmologic tolerability.
    Mariani L; Formelli F; De Palo G; Manzari A; Camerini T; Campa T; Di Mauro MG; Crippa A; Delle Grottaglie M; Del Vecchio M; Marubini E; Costa A; Veronesi U
    Tumori; 1996; 82(5):444-9. PubMed ID: 9063520
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colon cancer: a USA viewpoint.
    Lipkin M
    IARC Sci Publ; 1996; (136):53-61. PubMed ID: 8791116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.